Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 6998 matches for

The Oxford Vaccine Group in the Department is currently looking to recruit healthy adults aged between 18 to 60 in a study investigating how the adult immune system responds to a new meningococcal B vaccine.

Investigating Meningococcal Vaccines in Adults
Investigating Meningococcal Vaccines in Adults

Similar stories

Study shows urgent change needed to reduce deaths from malaria and meningitis in comatose African children

Results of two parallel studies show that one in four African children hospitalised with malaria and coma have an additional infection, and that giving antibiotics with antimalarials could help reduce death rates of comatose children.

Spotlight on Magdalen College Chapel for Rare Disease Day

New partnership to advance public health and life science research collaboration in West Africa

New study shows that early support for children living in marginalised communities can improve their developmental outcomes

Oxford and partners lead on two new MRC Centres to create cutting-edge gene therapies

Trial results for first vaccine against blood-stage malaria show it is well-tolerated and offers effective protection